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This journal is ª The Royal Society ofComposition and functionality of bone aﬀected by
dietary glycated compounds
Cristina Delgado-Andrade,*a Irene Roncero-Ramos,a Jose´ Carballo,b
Jose´ A´ngel Ruﬁa´n-Henares,c Isabel Seiquera and Mar´ıa Pilar Navarroa
Our aim was to investigate the eﬀects of Maillard reaction products (MRPs) from bread crust (BC) on bone
composition and its mechanical properties, determining whether any such eﬀects are related to the
molecular weight of diﬀerent MRPs. For 88 days after weaning rats were fed a control diet or diets
containing BC, or its soluble low molecular weight (LMW), soluble high molecular weight (HMW) or
insoluble fractions. Animals' food consumption and body weights were monitored. After sacriﬁce, the
femur, pelvic bone and tibia were removed for composition, physical and biomechanical properties
analysis. It was found that body and femur weights, density, volume and organic matrix decreased,
whereas pentosidine increased after consumption of experimental diets, especially in the HMW and
insoluble groups (104.7 and 102.9 mmol mol1 collagen) vs. the control group (41.7 mmol mol1
collagen). Bone stiﬀness fell by 50% in the LMW, HMW and insoluble groups and failure load and
energy to failure tended to decrease in the same animals after MRPs intake. Consumption of diets
containing assayed MRPs during growth leads to lower bone size and introduces some changes in its
mechanical behavior which appear to be related to an increase in the pentosidine level of bone.Introduction
The ability of bone to resist fracturing depends on its quantity,
architecture and turnover, but also on the intrinsic properties of
its constituent material.1 Bone is a sophisticated composite
material consisting of a mineral phase (mainly hydroxyapatite),
an organic phase and water with complex relationships among
them, inuencing bone strength. An imbalance between the
two major constituents or an alteration in their quality modies
the mechanical behaviour.2 The mineral phase, comprising
approximately 60% (w/w) of the bone, essentially contributes its
stiﬀness and strength; while the organic phase, consisting
mainly of collagen type I, is primarily responsible for providing
toughness and ductility.1,3,4 Also, the collagen content and its
cross-links could aﬀect the mechanical properties.5
Specically, non-enzymatic collagen cross-links, those
formed by the generation of advanced glycation end products
(AGEs) by the reaction of sugars within the extracellular space
with the amino groups of protein collagen, have been associated
with adverse eﬀects on the mechanical and biological functions
of bone.4,6 It has been reported that the formation of AGEs in, Estacio´n Experimental del Zaid´ın, CSIC,
ada, Spain. E-mail: cdelgado@eez.csic.es;
entos y Nutricio´n (ICTAN-CSIC), 28040,
, Facultad de Farmacia, Universidad de
ada, Spain
Chemistry 2013ribosylated human bones provokes a decrease in the specic
mechanical properties relating to post-yield behaviour;7 more-
over, the accumulation of collagen non-enzymatic cross-links in
bones has been correlated with an increase in collagen
stiﬀness.8
Pentosidine, a uorescent AGE, is used as a specic
biomarker of non-enzymatic cross-links in mechanical studies
in vivo since it has been reported to accumulate in bones with
aging.9 Wang et al.4 reported that the age-related increase in
pentosidine was associated with a decrease in human femur
toughness and post-yield properties. Saito et al.10 demonstrated
a decrease in bone strength in diabetic rats associated with an
increase in non-enzymatic cross-links measured as pentosidine.
The formation of AGEs can take place in the organism but
may also occur exogenously during food processing. These
compounds used to be called Maillard reaction products
(MRPs).11,12 It has been demonstrated that dietary MRPs can be
absorbed and therefore contribute to the AGEs formed in vivo,13
which accumulate in some tissues, playing a physiopathological
role in the development and progression of diseases such as
diabetes, osteoporosis and other age-related diseases.14 In this
process dicarbonyl compounds ingested seem to be implicated,
since they are highly reactive for reactions with proteins,
leading to the formation of peptide-bound amino acid deriva-
tives in the nal stages of the Maillard reaction.15
The aim of the present study was to investigate the eﬀects of
the consumption of MRPs from bread crust, as one of the major
sources of AGEs in the diet,16 on the composition and theFood Funct., 2013, 4, 549–556 | 549
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View Article Onlinephysical and biomechanical properties of bone, and also to
determine whether these possible eﬀects are related to the
molecular weight of diﬀerent MRPs present in the bread crust.Materials and methods
1 Preparation of diets
The AIN-93G puried diet for laboratory rodents (Dyets Inc.,
Bethlehem, PA) was used as the control diet.17 The bread crust
(BC) was supplied by a Spanish manufacturer of cereal-derived
food products. The process by which the BC was removed is
described in a previous work by Roncero-Ramos et al.18 Briey,
the BC was submitted to a pronase E digestion, obtaining
soluble and insoluble fractions. The soluble part was subjected
to ultraltration using a Biomax polyethersulphone membrane
(0.5 m2 size, 17.8 cm width  21 cm length, Millipore, MA, USA)
with 5 kDa NMWL. The fraction containing compounds with a
molecular weight higher than 5 kDa was retained (retentate,
high molecular weight, HMW) whilst the fraction containing
compounds with a weight below 5 kDa was ltered (ltrate, low
molecular weight, LMW). BC and all the fractions obtained were
lyophilized, powdered, homogenized and used for the formu-
lation of diets. BC was added to the AIN-93G diet to reach a nal
concentration of 10% (w/w). This diet was termed BC. Since
MRPs absorption can be aﬀected by the molecular weight,19 the
soluble LMW, soluble HMW and insoluble fractions were used
to prepare other diets aimed to determine the possible formu-
lation responsible for the observed eﬀects. Fractions were
individually added to the AIN-93G diet in the same proportion
as they were present in the 10% of BC, being calculated from the
recovery of each fraction aer pronase E digestion and the
ultraltration process. These diets were termed LMW, HMW
and insoluble, respectively.
The individual analysis of the diﬀerent diets revealed no
modication of the overall nutrient composition, compared
with the control diet (AIN-93G). The mean  SD nutrient
content of the diets was: moisture (%) 7.9 0.4; protein (g kg1)
168.4  4.0; fat (g kg1) 77.9  1.6; Ca (g kg1) 4.86  0.05 and
P (g kg1) 3.22  0.08.
The higher MRPs content in the diets prepared, with respect
to the control diet, was established by analysing the furosine
and hydroxymethylfurfural (HMF) contents as described in the
study by Roncero-Ramos et al.182 Biological assays
Thirty weanling (21 day old) Wistar female rats weighing 40.15
 0.16 g (mean  SE) were used in the study. They were
randomly distributed into ve groups (6 animals per group) and
each group was assigned to one of the dietary treatments. The
animals were individually housed in metabolic cages in an
environmentally controlled room under standard conditions
(temperature: 20–22 C with a 12 h light–dark cycle and 55–70%
humidity). The rats had ad libitum access to their diets and
demineralised water (Milli-Q Ultrapure Water System, Millipore
Corps., Bedford, MA, USA).550 | Food Funct., 2013, 4, 549–556On day 88, aer being starved overnight, the animals were
anaesthetised with sodium pentobarbital (5 mg per 100 g of
body weight) (Abbott Laboratories, Granada, Spain) and
terminal exsanguination was performed by a cannulation of the
carotid artery. The right femur, tibia and pelvic bone were
removed, weighed and frozen at 80 C until analysis.
All management and experimental procedures carried out in
this study were in strict accordance with the current European
regulations (86/609 E.E.C.) regarding laboratory animals.
The Bioethics Committee for Animal Experimentation at our
institution (EEZ-CSIC) approved the study protocol.3 Analytical techniques
3.1 Analysis of the physical parameters of the femurs.
Whole femurs were removed from the animals by breaking the
joints that bound them to adjacent bones and preserving their
epiphysis and diaphysis. Before composition and mechanical
testing, the bone specimens were cleared of external so-tissue
adhered to the surface and then weighed. To determine their
water content, avoiding the possible promotion of the Maillard
reaction in the tissue by applying high temperatures, bones were
also weighed aer an overnight drying at room temperature.
The femur length was measured using an analog Vernier
caliper and the density of each femur was determined in trip-
licate, using a water picnometer (25 cm3, Pobel, Madrid, Spain).
Briey, this value was calculated gravimetrically, as the ratio
between the femur weight in air and in water. The femur volume
was estimated by dividing the bone weight by its density.
3.2 Bone densitometry determination. Bone mineral
density (BMD) and bone mineral content (BMC) were measured
by dual-energy X-ray absorptiometry (DEXA). BMD and BMC
measurements were performed with a bone densitometer
Norland Stratec (Norland Corp., Fort Atkinson, WI, USA) using
special soware for small animals, providing data as a function
of the area considered and yielding comparable data between
animals. The BMD and BMC were measured in the entire right
femur and pelvic bone.
3.3 Determination of the main constituents of the femur.
The water content was determined as described above. The
femurs were then dry-ashed in a muﬄe furnace (Selecta,
Mod.366, Barcelona, Spain) at 450 C aer which the white
ashes obtained were weighed; the weight of the organic phase
was calculated as the diﬀerence between the weights of the
ashes and the bones. The white ashes were dissolved with HCl–
HNO3–H2O (1 : 1 : 2). The calcium analyses in all samples were
carried out by ame atomic absorption spectroscopy (AAS) in a
PerkinElmer Analyst 700 Spectrophotometer (Norwalk, Conn.,
USA). Standard solutions were prepared from a stock Tritisol
solution of calcium (Cl2Ca in 6.5% HCl, 1000 mg Ca).
Lanthanum chloride was added to the samples and standards
to reach a nal concentration of 0.3%. Phosphorus was deter-
mined colorimetrically at 820 nm in a spectrophotometer
(Shimadzu UV-1700, Model TCC-240A, Columbia, USA) by the
vanadomolybdate procedure (AOAC, 1990).
3.4 Analysis of the biomechanical properties of the bones.
Tibias were cleaned in the same way as described for femursThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlineonce removed from the animals and fat inside was not extracted
for the tests. Mechanical properties of the whole tibia were
determined using a three-point bending test. The bones were
loaded perpendicularly to their long axis with aWarner–Bratzler
device adapted to a universal testing machine (Model 4501,
Instron Engineering Corp., Canton, MA, USA) connected to a
Vectra ES/12 computer (Hewlett Packard Company, WA, USA).
Load–displacement curves were derived applying a cell of 5 kN
of total load capacity at a crosshead speed of 20 mm min1 to
the bone diaphysis.
The following parameters were determined from the load–
displacement curve: displacement to failure (mm) as the elon-
gation to the failure load; the failure load (N) as the maximum
load sustained by the specimen at breaking; the bending stiﬀ-
ness (Nmm1) as the slope of the linear portion of the curve; the
energy to failure (mJ) as the area under the curve to failure load.
3.5 Pentosidine content in tibia. Pentosidine was deter-
mined following the method described by Takahashi et al.20 for
sample hydrolysis and the method of Scheijen et al.21 for the
chromatographic separation. Briey, 150 mg of powdered rat
tibia was hydrolysed with 3 mL 6.0 M HCl at 110 C for 23 h in a
Pyrex screw-cap vial with PTFE-faced septa. High-purity N2 gas
was bubbled through the solution for 2 min. A 500 ml portion of
the hydrolysate was evaporated under vacuum and the dried
sample dissolved in 200 mL of 25 mM citric acid. Finally, 50 mL
of the sample was injected into a liquid chromatograph (Jasco
LC Pump, Model PU-2089, Jasco Corporation, Madrid, Spain)
coupled to a uorescence detector (Jasco, Model FP-2020) and a
computing integrator connected to a PC. Pentosidine was
separated on a ODS-B 5 mm column (Tracer Excel 120 ODS-B
5 mm, 250 mm  4.0 mm i.d., Tecknokroma, Barcelona, Spain)
thermostatted at 32 C. Solvent A was 25 mM citric acid and
solvent B was (50/50, v/v) ACN–25 mM citric acid. A linear
gradient was started at 99% solvent A which was changed aer
15 minutes to 90% solvent A. Aer cleaning the column with
100% solvent B for 5 minutes the column was equilibrated for 8
min at the initial composition. The ow rate was 1 mL min1
and the uorescence detector was set at lex¼ 335 nm and lem¼
385 nm. Duplicate samples were analysed. The external stan-
dard method was used for the quantication. A standard stock
solution containing 245 pmol mL1 of pentosidine was used to
prepare the working standard solution. The calibration was
performed with a pentosidine standard curve (r2 ¼ 0.9994).
Collagen determination was performed by quantitation of
the released 4-hydroxyproline in hydrolysates of samples using
the technique described by Jamall et al.22 Briey, a 7 point curveTable 1 Physical parameters of femurs after feeding rats the diﬀerent dietsa
Group Weight (g) Length (cm
Control 0.59  0.05A 3.39  0.05
BC 0.51  0.02B 3.26  0.08
LMW 0.51  0.02B 3.30  0.04
HMW 0.51  0.02B 3.31  0.04
Insoluble 0.49  0.01B 3.28  0.04
a Values are means  SE, n ¼ 6. Diﬀerent letters within a column indicat
This journal is ª The Royal Society of Chemistry 2013of standard hydroxyproline was constructed ranging from 0 to
1.6 mg of hydroxyproline in 1.2 mL of 50% isopropanol. 50 mL of
a 1 : 80 hydrolysate sample dilution was added to each point.
The nal volume was adjusted to 1.2 mL with isopropanol :
water (50 : 50) and then 200 mL of 0.58% chloramine T solution
(in citrate buﬀer pH 6.0) was added. Aer 10 minutes, 1 mL of
Ehrlich reagent was added and the sample was then incubated
for 90 minutes at 50 C in a water bath. Finally, the samples
were cooled in water at room temperature for 15 minutes and
their absorbances at 558 nm were read using water as a refer-
ence. The collagen content was calculated assuming that the
collagen mass was 6.0 times the hydroxyproline mass, as
determined from the composition of rat dentin collagen.23
4 Statistical analysis
All data were statistically tested by one-way analysis of the
variance (ANOVA), followed by Duncan's test to compare means
that showed a signicant variation (P < 0.05). Analyses were
performed using Statgraphics Plus, version 5.1, 2001. Evalua-
tion of the relationship between the diﬀerent variables was
carried out by computing the relevant correlation coeﬃcient
(Pearson's linear correlation), whereas the multiple relation-
ships among variables were evaluated by a multiple regression
test (Durbin–Watson's correlation), both at the P < 0.05 con-
dence level. All data were also analysed by one-way analysis of
the variance (ANOVA) considering the nal body weights of
animals as covariate. When diﬀerences among the treatments
were signicant (P < 0.05) as determined by the F test in the
ANOVA, means were separated using the Duncan's test.
Results
Physical properties of the femurs are shown in Table 1. The
femur weight was signicantly less in all animals fed the BC diet
and its fractions with respect to the control diet. Bone density
also fell in all animals fed the experimental diets, although only
slightly within the BC group. The femur length remained
unchanged in all groups, but the volume decreased
signicantly.
Regarding bone composition (Fig. 1), the mineral phase
content in the femurs did not vary and no signicant diﬀer-
ences were detected in calcium and phosphorus contents.
Nevertheless, the organic phase was signicantly lower in the
animals fed diets containing BC derivatives (Fig. 1).
The femur BMD tended to decrease in all experimental
groups, compared with the control one, but the diﬀerence was) Density (g cm3) Volume (cm3)
1.49  0.03A 0.44  0.02A
1.43  0.04AB 0.38  0.01B
1.36  0.03B 0.39  0.02B
1.37  0.04B 0.39  0.01B
1.38  0.02B 0.37  0.01B
e signicant diﬀerences between groups (P < 0.05).
Food Funct., 2013, 4, 549–556 | 551
Fig. 1 Major constituents of femur in rats fed the diﬀerent diets (mean  SE, n ¼ 6). Diﬀerent letters within a parameter indicate signiﬁcant diﬀerences between
groups (P < 0.05).
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View Article Onlineonly signicant in the insoluble group, with a reduction of 7.3%
(Fig. 2). The BMC of this bone did not experience any signicant
change, and neither did the BMD and BMC in the pelvic bone
(Fig. 2).
Data corresponding to mechanical properties of the tibia are
shown in Table 2. No modication was observed in bone
displacement to failure, but there was a general reduction in
bone diameter aer consumption of BC and its derivatives.
Bone bending stiﬀness signicantly decreased, by almost 50%
in the tibias from the LMW, HMW and insoluble groups
compared with the control and the BC groups. There were no
changes in the failure load or the energy to failure in any of the
experimental groups, but there was a marked decline in the
latter two parameters in the BC group.
The pentosidine concentration in the tibia increased
signicantly in all the animals fed the experimental diets
(Fig. 3), with respect to the control group. The highest values
were observed in the HMW and insoluble groups (104.7 and
102.9 mmol mol1 collagen, respectively vs. 41.7 mmol mol1
collagen in the control animals).Fig. 2 Bone mineral density (BMD) and bone mineral content (BMC) measured by
n ¼ 6). Diﬀerent letters within a parameter indicate signiﬁcant diﬀerences between
552 | Food Funct., 2013, 4, 549–556Discussion
1 Composition and physical properties
During growth, a maturation process takes place in the bones,
involving changes in thematrix composition and in the physical
and chemical characteristics of the bone mineral.24 Burnell
et al.24 described an initially rapid increase in the bone matrix
(organic phase) in a normal maturation process, during which
the mineral phase follows a progressive but diminishing
increase. The most intense period of bone maturation in rats
takes place between 4 and 22 weeks, when the mineral density
increases slowly up to 22 weeks, whilst at the same time there is
a faster organic growth phase that slows down from 8 weeks.
Since animals of the present study took part in other metabolic
assays,18,25 they began the trial at weaning (weighing 40.15 
0.16 g; mean  SE). At the end they reached the age of 15 weeks
and so these normal physiological changes should be taken into
account when interpreting the data. In previous works we have
already reported that global food intake of our experimental
animals was lower than in the control ones, as were bodydual-energy X-ray absorptiometry (DEXA) in femur and pelvic bones (mean  SE,
groups (P < 0.05).
This journal is ª The Royal Society of Chemistry 2013
Table 2 Mechanical properties of the tibia determined by a three-point bending testa
Control BC LMW HMW Insoluble
Displacement to failure (mm) 0.94  0.16 0.87  0.09 0.87  0.10 1.10  0.13 0.98  0.03
Diameter (mm) 2.68  0.27A 2.27  0.10B 2.30  0.08AB 2.15  0.08B 2.18  0.06B
Bending stiﬀness (N mm1) 218.87  21.62A 238.73  18.88A 152.23  18.50B 139.90  18.29B 109.25  10.50B
Failure load (N) 114.95  21.11 102.97  6.38 90.77  10.01 82.68  3.60 85.23  11.57
Energy to failure (mJ) 38.77  12.77 21.95  1.99 26.25  4.22 26.05  2.85 26.74  3.13
a Values are means  SE, n ¼ 6. Diﬀerent letters within a row indicate signicant diﬀerences between groups (P < 0.05).
Fig. 3 Pentosidine content in tibia of rats fed the diﬀerent diets (mean  SE,
n ¼ 6). Diﬀerent letters indicate signiﬁcant diﬀerences between groups (P < 0.05).
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View Article Onlineweights (247.6  5.1; 235.0  4.4; 236.3  7.2; 227.5  5.8 and
220.7  4.0 g for control, BC, LMW, HMW and insoluble groups
respectively),18 leading to smaller bones, probably in the earlier
stages of growth.
The physical characteristics of the femurs of the control rats
were normal in terms of size, density and weight26–28 (Table 1),
whereas the femurs of the experimental rats were signicantly
smaller in weight and volume, but similar in length. A signi-
cant correlation between the femur weight and the nal body
weight of the animals (r¼ 0.650; P < 0.001) was found18 which is
in line with the observations of Fukuda and Iida29 who reported
that the growth period is the only stage during which body
weight and BMD are closely correlated. Bone density signi-
cantly decreased in all groups fed diets containing MRPs,
although the BC group showed only a tendency in this direction.
Since total bone density includes both organic and mineral
mass,30 and the latter did not vary (Fig. 1), the signicant
decrease of the organic matrix, which correlated with the femur
density (r¼ 0.490; P¼ 0.007), was responsible for the bonemass
loss. In the study by Burnell et al.24 performed on rats with lower
food intakes and consequently lower body weight gains aer 12
weeks (around 30%), a decrease in femur densities was also
observed. Those bones contained lower amounts of mineral and
hydroxyproline, but with a more pronounced reduction in
hydroxyproline. In our assay, the decline in the bone organic
matrix could have been caused by a delay in the bone growth
related to the lower body weight. However this circumstance
was not the only responsible factor but also MRPs intake
through the diets, since a parallel statistical treatment consid-
ering nal animal weights as covariate demonstrated that the
bone organic matrix of animals fed MRPs diets was alwaysThis journal is ª The Royal Society of Chemistry 2013signicantly lower than those fed the control diet (P¼ 0.004). In
this sense, it has been established that dicarbonyl compounds
ingested coming from theMaillard reaction could be implicated
in the formation of peptide-bound amino acid derivatives.16
Thus, non-enzymatic glycation of bone collagen could be facil-
itated due to the existence of these highly reactive species, since
the presence of mineral in bone does not prevent collagen
glycation.8
The non-enzymatic cross-links which contribute to deterio-
rating biological andmechanical bone properties4 increase with
aging31 and are exacerbated in diabetes-related pathologies.32
Pentosidine is one of the most commonly studied AGEs, due
to its participation in non-enzymatic cross-links. Values of
pentosidine found in the literature vary widely both intra- and
inter-species. In this respect, very few studies have been per-
formed with rats, and results are substantially diﬀerent, ranging
from 0.1–1 mmol mol1 collagen for Wistar rats10 to 40–92
mmol mol1 collagen for F344 rats,33 a similar interval to our
results (Fig. 3). Pentosidine signicantly increased in all groups
compared to the control one. The consumption of BC and
especially of isolated HMW and insoluble fractions increased
pentosidine concentrations (104.7 and 102.9 mmol mol1
collagen, respectively), reaching the values reported by Silva
et al.33 for diabetic rats. Therefore, our data reveal that more
advanced and higher molecular weight compounds could be
the main factors responsible for the eﬀect, although the LMW
fraction also exerted a residual inuence. It must be underlined
that the eﬀects do not seem to be additive, but rather are
modulated when the compounds are consumed as a real food,
BC, subjected to a normal digestive process. The covariate
analysis establishing nal body weight as a correction factor
demonstrated that pentosidine increased as a consequence
of MRPs intake, independently of the growth rate reached
(P < 0.001).
Although according to Kankova and Sebekova34 ingested
AGEs are absorbed in the small intestine and contribute to
increasing endogenously formed AGEs, to date no studies have
established the accumulation of dietary AGEs in the tissues,
especially in bone. To the best of our knowledge, only the assay
by Mikulikova et al.32 using a diet with a high content of fruc-
tose, expected to increase plasma AGEs, has demonstrated a
dietary-provoked increase in pentosidine levels in collagen-rich
tissues.
The BMD values measured in our assay animals were in line
with those reported in other studies for this stage of growth.35
Consistent with the lack of changes in ash, calcium andFood Funct., 2013, 4, 549–556 | 553
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View Article Onlinephosphorus contents, BMC in the femur and pelvic bone did
not vary signicantly (Fig. 2). BMD in the pelvic bone was also
unchanged, but BMD in the femur did tend to decrease slightly,
although it was only signicant in the rats fed the insoluble
diets, and these animals were also those which had the lowest
food intake and body weight.18
The scientic literature relating BMD data measured by
DEXA and AGEs accumulation is not available. In an earlier
study by our research group with rats fed MRPs from a glucose–
lysine model system, the pentosidine content was much higher
than in the rats in the present assay. No change was found in
BMC of the pelvic bone and femur, whereas a slight decrease
was observed in BMD in the pelvic bone.36 In assays performed
in diabetic rats with the same age, BMD measured by pQCT
decreased in several long bones, aﬀecting trabecular rather than
cortical bones.26,33
2 Biomechanical properties
In the load–displacement curve, no diﬀerences were observed
among the displacement to failure, in the groups assayed
(Table 2). Similarly, in vitro glycation assays on rat bones did not
reveal changes in the displacement of tibia or femur using the
same kind of test.37 The diabetic pathology is a disorder whose
progression and development is tightly linked with the in vivo
levels of AGEs due to their involvement in the biochemical
pathways related to this illness. Experiments with diabetic rats
have shown no signicant modications in the displacement of
tibia or femur, even at advanced stages of the disease.26 Thus,
although AGEs accumulation in bone has been related to the
loss of elasticity, this was not observed in our assay.
Bone bending stiﬀness signicantly decreased in animals
fed LMW, HMW and insoluble diets with respect to control and
BC diets. Stiﬀness mainly depends on bone mineral, which was
unchanged in the present assay. Stiﬀness was positively corre-
lated with density (r ¼ 0.558, P ¼ 0.002) and the amount of
organic matrix (r ¼ 0.424, P ¼ 0.022), and negatively with the
pentosidine content (r¼0.520, P¼ 0.004). This result appears
to conict with other ndings describing increased stiﬀness
due to AGE accumulation in bones.8,38 The in vitro assays by
Vashishth et al.8working with demineralised bones subjected to
glycation by ribose incubation, demonstrated that this treat-
ment enhances stiﬀness, although the eﬀects were slighter with
mineralised specimens. In spite of the higher pentosidine
values found in our experiment, bone bending stiﬀness
decreased, and so there should be other countered factors
conditioning this eﬀect. In fact, the multiple regression analysis
(Durbin–Watson's correlation) performed indicated that 92% of
the changes in bone stiﬀness were accounted for by the factors
of density and pentosidine content, in accordance with the
following equation:
[stiffness (N mm1) ¼ 1.07pentosidine (mmol mol1 collagen)
+ 179.7density (g cm3)]
in which bone density is the main factor responsible, and the
participation of pentosidine is inversely eﬀective, and to a
minor degree. Prisby et al.26 reported that advancing diabetes,554 | Food Funct., 2013, 4, 549–556which is associated with high AGEs levels in serum,34 leads to
smaller bones, with lower weights and less stiﬀness, which is in
line with our results for the LMW, HMW and insoluble diets,
but not the BC group. According to the above-mentioned
authors, the growth delay and the reduction in the cross-
sectional dimensions of the large bones could be responsible
for this outcome. This conclusion is consistent with our results,
since the tibia diameters of the animals fed BC and its fractions
were smaller than those of the control animals. Not only was the
delayed growth the cause of the observed eﬀect, but also the
MRPs consumption, as established by the statistical covariate
analysis. When the nal animal weights were used as a
correction factor, the stiﬀness data showed the same statistical
signicance as described in Table 2 (P < 0.001).
Several studies have shown that bone strength is deter-
mined by bone mass and that its stiﬀness is mainly dependent
on the mineral content.1 In our work, in the tibias of animals
fed BC derived fractions, the failure load tended to decrease,
especially in groups consuming the higher molecular weight
compounds (HMW and insoluble groups). This decline,
although without statistical signicance, was more than 25%,
which is in agreement with the reduction rates described by
Silva et al.33 in diabetic rats. Non-enzymatic cross-links intro-
duce structural changes which are a determinant of bone
strength. Moreover, their presence may reduce strength by
modifying osteoblastic and osteoclastic activity,39 an eﬀect that
has been shown aer in vitro treatment with sugars40 or during
aging.41 Thus, rats fed the isolated fractions from BC had
higher deoxypyridinoline values in urine,18 suggesting a situa-
tion of increased bone resorption or greater turnover. Only the
study by Garnero et al.40 has reported that a small accumula-
tion of AGEs, measured as pentosidine, has a positive eﬀect on
bone strength.
Bones in the control rats tolerated higher energies to failure,
although the diﬀerence was not statistically signicant.
This parameter correlated positively with the organic matrix
(r ¼ 0.549, P ¼ 0.002) and it is known that the organic phase is
an important contributor of bone resistance42 and that bone
resistance decreases with collagen deterioration.43 As
mentioned above, AGEs are inversely correlated with bone
resistance38 and products such as pentosidine would partially
explain this fact, since their accumulation reduces the post-
yield energy dissipation of bone tissue prior to fracture.44
Nevertheless, and consistent with our own data, diabetic
disease has usually not been found to produce severe eﬀects on
the energy at the point of failure.33 In the cases where some
eﬀects have been detected, the changes take place aer ve26 or
eight10 months of induced diabetes.
In general, consumption of the assayed diets, and especially
in the case of the isolate fractions, led to smaller animals and
bones, which modied certain mechanical properties,
producing less stiﬀ bones with a lower ability to withstand force
and absorb energy to failure. Thus, although the covariate
analysis showed a direct eﬀect of the consumption of MRPs
derived from BC on bone stiﬀness, diﬀerences in bone size and
maturation appeared to account for almost all changes
observed in the mechanical properties.This journal is ª The Royal Society of Chemistry 2013
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View Article OnlineTo sum up, our data suggest that the consumption of diets
containing bread-derived products, especially those containing
its isolate fractions, leads to a reduction in food intake, which
seems to delay bone development at a crucial stage of growth,
aﬀecting bone characteristics.
Despite our results not being completely conclusive, we
guess there is a more direct eﬀect of the consumption of bread-
derived MRPs on bone, especially related to the presence of the
higher molecular weight compounds. However the manifesta-
tions were weaker when the compounds are consumed as a
whole food, BC.
Although further study in this eld is needed, our study
suggests that dietary AGEsmay inuence bone health in healthy
individuals, hence the importance of diet in preventing
degenerative diseases.Conﬂicts of interests
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